Recombinant IGF1, IGF2 (Xentuzumab Biosimilar) antibody

Catalog No. ABIN7598106

This Humanized Chimeric antibody specifically detects IGF1, IGF2 (Xentuzumab Biosimilar) . It exhibits reactivity toward Human.

Quick Overview for Recombinant IGF1, IGF2 (Xentuzumab Biosimilar) antibody (ABIN7598106)

Target: IGF1, IGF2 (Xentuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Grade: Research Grade

Product Details anti-IGF1, IGF2 (Xentuzumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Xentuzumab Biosimilar Antibody

Specificity: IGF-I, IGF1, Mechano growth factor, MGF, Insulin-like growth factor I, IBP1, Somatomedin-C, IGF2, IGF-II, Insulin-like growth factor II, T3M-11-derived growth factor, Somatomedin-A

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 lambda

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for IGF1, IGF2 (Xentuzumab Biosimilar)

Target: IGF1, IGF2 (Xentuzumab Biosimilar)

Alternative Name: Xentuzumab Biosimilar

Target Type: Biosimilar

Background: IGF-I, IGF1, Mechano growth factor, MGF, Insulin-like growth factor I, IBP1, Somatomedin-C, IGF2, IGF-II, Insulin-like growth factor II, T3M-11-derived growth factor, Somatomedin-A

UniProt: P05019, P01344

CAS-No: 1417158-65-6